A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)

NCT07748403 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Wilson Disease
Wilson's Disease
Wilsons Disease

Interventions

DRUG: PM577a

Sponsor

Prime Medicine, Inc.